Search results for " Hearing"

showing 10 items of 301 documents

Increased amplitudes of distortion product otoacoustic emissions in patients with unilateral acoustic neuroma.

2004

We present a case series of 4 patients with a unilateral acoustic neuroma and increased amplitudes of the distortion products of otoacoustic emissions (DPOAEs) at the low- and middle- frequency bandwidth on the involved side compared to the uninvolved side despite a 28-dB hearing level (HL) worse (compared to the uninvolved side) pure-tone hearing threshold average for standard audiometric frequencies between 1 and 6 kHz at the involved side. In 3 of these patients, 2 with an inferior vestibular nerve origin of the acoustic neuroma and one in whom the nerve of origin could not be unequivocally defined, the tumor was extending extrameatally. One patient had a purely intrameatal acoustic neur…

AdultMalemedicine.medical_specialtyDistortion productOtoacoustic Emissions SpontaneousAcoustic neuromaAudiologyHearing Loss Unilateralotorhinolaryngologic diseasesmedicineHumansIn patientCochleaRetrospective StudiesAbsolute threshold of hearingbusiness.industryElectronystagmographyNeuroma AcousticMiddle AgedVestibular nervemedicine.diseaseMagnetic Resonance ImagingAmplitudeOtorhinolaryngologyHearing levelAudiometry Pure-ToneFemalesense organsbusinessORL; journal for oto-rhino-laryngology and its related specialties
researchProduct

Assessing audiological, pathophysiological and psychological variables in tinnitus patients with or without hearing loss

2010

The aim of this work is to study the characteristics of tinnitus both in normal hearing subjects and in patients with hearing loss. The study considered tinnitus sufferers, ranging from 21 to 83 years of age, who were referred to the Audiology Section of Palermo University in the years 2006–2008. The following parameters were considered: age, sex, hearing threshold, tinnitus laterality, tinnitus duration, tinnitus measurements and subjective disturbance caused by tinnitus. The sample was divided into Group1 (G1), 115 subjects with normal hearing, and Group2 (G2), 197 subjects with hearing loss. Especially for G2, there was a predominance of males compared to females (P = 0.011); the highest…

AdultMalemedicine.medical_specialtyHearing lossHearing Loss SensorineuralAudiologyIrritabilityTinnitus Normal hearing Hearing lossTinnitusAudiometryotorhinolaryngologic diseasesmedicineHumansDepression (differential diagnoses)AgedAged 80 and overAbsolute threshold of hearingmedicine.diagnostic_testbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseVestibular Evoked Myogenic PotentialsSettore MED/32 - AudiologiaSettore MED/31 - OtorinolaringoiatriaOtorhinolaryngologyAcoustic Impedance TestsItalyEvoked Potentials AuditoryAnxietySensorineural hearing lossFemalemedicine.symptomAudiometrybusinessTinnitus
researchProduct

DPOAE‐Grams in Patients with Acute Tonal Tinnitus

2005

To investigate cochlear outer hair cell function in patients with acute tonal tinnitus and normal or near-normal hearing threshold.Prospective controlled study in an academic tertiary health center. Distortion products of otoacoustic emissions (DPOAE)-grams of 32 ears with acute tonal tinnitus and normal hearing or minimal hearing loss were compared with those of 17 healthy nontinnitus ears.Tinnitus ears exhibited relatively increased amplitudes of DPOAE at high frequencies (4-6.3 kHz) when compared with the group of healthy ears and relatively decreased DPOAE amplitudes at middle frequencies (1650-2400 Hz). Statistically significant ( P0.01) increased mean values of DPOAE amplitudes were o…

AdultMalemedicine.medical_specialtySound SpectrographyAdolescentHearing lossHearing Loss SensorineuralLoudness PerceptionOtoacoustic Emissions SpontaneousAudiologyFunctional LateralityTinnitus03 medical and health sciences0302 clinical medicineReference Valuesotorhinolaryngologic diseasesmedicineHumansIn patientProspective StudiesPitch Perception030223 otorhinolaryngologyOuter hair cellsCochleaAgedAbsolute threshold of hearingbusiness.industryAuditory ThresholdMiddle AgedHair Cells Auditory Outermedicine.anatomical_structureAcoustic StimulationOtorhinolaryngology030220 oncology & carcinogenesisReference valuesAcute DiseaseFemaleSurgerysense organsHair cellmedicine.symptombusinessTinnitusOtolaryngology–Head and Neck Surgery
researchProduct

Alterations in speech and voice in patients with mucopolysaccharidoses.

2013

The mucopolysaccharidoses are a group of lysosomal disorders characterized by abnormal accumulation of glycosaminoglycans within cell lysosomes leading to a variety of signs and symptoms including alterations in speech and voice production. These changes were analysed in 44 patients with mucopolysaccharidosis (MPS) types I, II, and VI using standardized protocols. Compared to healthy individuals the diadochokinetic rate for the fast repetition of syllables was slower and more irregular, the voice-onset time for the voiceless consonant /p/ was shorter, and most patients had a hoarse voice. The fundamental frequency (F0) of sustained spoken vowels was in the normal range for most women and ch…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentVoice QualityMucopolysaccharidosisSigns and symptomsAudiologySpeech AcousticsSpeech and HearingYoung AdultSex FactorsArts and Humanities (miscellaneous)PhonationSpeech Production MeasurementmedicineHumansIn patientChildHoarsenessVoice Disordersbusiness.industryVoice-onset timeEnzyme replacement therapyAcousticsMiddle AgedMucopolysaccharidosesLPN and LVNVoice productionmedicine.diseaseHoarse voiceCase-Control StudiesChild PreschoolVoiceAudiometry Pure-ToneFemalemedicine.symptombusinessLogopedics, phoniatrics, vocology
researchProduct

[Clinical and radiological evolution of a group of untreated acoustic neuromas].

2013

Abstract Introduction The acoustic neuroma is a benign tumour that originates in the vestibular branch of the eighth cranial nerve. The main treatment is surgery, but many authors suggest that with elderly patients or in small neuromas we can opt for watchful waiting. Methods This was a retrospective study from 2007 to 2013 that included 27 patients diagnosed of acoustic neuroma that had not been treated due to the size of the tumour, age and comorbidities, or by patient choice. We evaluated overall condition, hearing thresholds, degree of canal paresis and central disorders. Results After 6 years of follow up, clinical manifestations of 18 patients remained unchanged, 5 patients underwent …

AdultMalemedicine.medical_specialtyTime FactorsHearing lossmedicine.medical_treatmentAcoustic neuromaAudiologyotorhinolaryngologic diseasesmedicineHumansWatchful WaitingParesisAgedRetrospective Studiesmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingGeneral MedicineNeuroma AcousticMiddle Agedmedicine.diseaseMagnetic Resonance ImagingSensorineural hearing lossFemalesense organsRadiologymedicine.symptomUnilateral hearing lossbusinessWatchful waitingTinnitusActa otorrinolaringologica espanola
researchProduct

Clinical observations and risk factors for tinnitus in a Sicilian cohort.

2014

The aims of this study were to determine the distribution of risk factors associated with tinnitus analysing their role in the development of tinnitus and the effects of their interaction; to evidence the importance of a suitable and adequate clinical and audiologic assessment to avoid those modifiable risk factors responsible for cochlear dysfunction and tinnitus onset. 46 subjects with tinnitus and 74 controls were studied according to: age, sex, Body Mass Index (BMI), neck circumference, tobacco smoking, feeling fatigue or headache, self reporting snoring, hypertension, diabetes, coronary heart disease, and/or hyperlipidemia, and laboratory finding as lipid profile and levels of reactive…

AdultMalemedicine.medical_specialtyTinnitus Hearing loss Risk factors Multi-frequency audiometry TEOAEAdolescentHearing lossOtoacoustic Emissions SpontaneousAudiologyMulti-frequency audiometry TEOAERisk AssessmentTinnitusYoung AdultAudiometryRisk Factorsotorhinolaryngologic diseasesmedicinePrevalenceHumansSicilyAgedAged 80 and overUnivariate analysismedicine.diagnostic_testbusiness.industrySettore MED/44 - Medicina Del LavoroGeneral MedicineMiddle Agedmedicine.diseaseComorbiditySettore MED/32 - AudiologiaSettore MED/31 - OtorinolaringoiatriaOtorhinolaryngologyCohortTinnitus Hearing loss Risk factorFemalemedicine.symptomAudiometrybusinessLipid profileBody mass indexTinnitusFollow-Up StudiesEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
researchProduct

Sudden Sensorineural Hearing Loss: Results of intratympanic steroids as salvage treatment

2012

Objective: The aim of the present study was to verify the efficacy and the safety of intratympanic dexamethasone to treat sudden sensorineural hearing loss as salvage therapy. Materials and methods: A prospective study was conducted on patients affected by idiopathic sudden hearing loss who were treated before with some systemic therapy, but without recovery of the hearing The patients able to undergo the study, but who refused salvage treatment were considered as control group. A solution of Dexamethasone 4 mg/ml was then injected through the posterior–inferior quadrant filling completely the middle ear. The follow-up in the following 6 months included an audiogram every month. Results: Th…

AdultMalemedicine.medical_specialtyTympanic MembraneAdolescentNeurosensorial Hearing Loss Steroids treatmentHearing lossHearing Loss SensorineuralSalvage therapyInjections IntralesionalAudiologyRisk AssessmentSystemic therapyDexamethasoneYoung AdultConfidence IntervalsOdds Ratiootorhinolaryngologic diseasesmedicineHumansProspective StudiesProspective cohort studyDexamethasoneAgedSalvage TherapyAnalysis of VarianceAbsolute threshold of hearingmedicine.diagnostic_testbusiness.industryAudiogramHearing Loss SuddenMiddle AgedTreatment OutcomeSettore MED/31 - OtorinolaringoiatriaOtorhinolaryngologyCase-Control StudiesAnesthesiaAudiometry Pure-ToneFemaleAudiometrymedicine.symptombusinessFollow-Up Studiesmedicine.drugAmerican Journal of Otolaryngology
researchProduct

Treatment of sudden sensorineural hearing loss with transtympanic injection of steroids as single therapy: a randomized clinical study.

2011

The aim of this study was to verify the efficacy and the safety of transtympanic dexamethasone to treat sudden sensorineural hearing loss as first and single drug method. Considering ethical implication of performing a mininvasive procedure on middle ear, we matched such proposed treatment with systemic prednisone administration that represents the widest adopted protocol. Randomized prospective study was conducted. The inclusion criterion was a sudden sensorineural hearing loss of at least 30 dB across three contiguous frequencies over a period of 24 h. Group A received transtympanic steroid injections; Group B received oral administration of steroids. 25 patients were treated with transty…

AdultMalemedicine.medical_specialtyTympanic MembraneHearing Loss SensorineuralAdministration OralInjections IntralesionalRisk AssessmentSeverity of Illness IndexDexamethasoneDrug Administration ScheduleAudiometryOral administrationPrednisoneSeverity of illnessmedicineHumansProspective StudiesProspective cohort studyDexamethasoneAgedAnalysis of Variancemedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryGeneral MedicineHearing Loss SuddenMiddle AgedSurgeryCochlea Deafness Round window Sudden sensorineural hearing loss Steroid TranstympanicTreatment OutcomeOtorhinolaryngologyOtorhinolaryngologyFemaleNeurosurgeryAudiometrybusinessmedicine.drugFollow-Up Studies
researchProduct

Intratympanic Dexamethasone/Hyaluronic Acid Mix as an Adjunct to Intravenous Steroid and Vasoactive Treatment in Patients With Severe Idiopathic Sudd…

2011

To evaluate differences in effectiveness (hearing recovery rates) between idiopathic sudden sensorineural hearing loss (ISSNHL) patients treated with intravenous therapy alone and patients treated with a combination of intravenous and intratympanic therapy.Retrospective case review.Tertiary referral hospital center.Ninety-four patients with moderate ISSNHL treated with an intravenous steroid and vasoactive regimen (duration of therapy, 9 ± 2.76 d) and 76 patients with severe ISSNHL treated with a combination regimen of intravenous and intratympanic therapy (duration of therapy, 10 ± 2.71 d) were reviewed. In the latter patients' group, a series of 3 intratympanic injections of a dexamethaso…

AdultMalemedicine.medical_specialtyTympanic MembraneHearing Loss Sensorineuralmedicine.medical_treatmentIntratympanic dexamethasoneDexamethasoneInjectionsSteroidchemistry.chemical_compoundVasoactiveInternal medicineHyaluronic acidotorhinolaryngologic diseasesmedicineHumansIn patientHyaluronic AcidGlucocorticoidsRetrospective Studiesbusiness.industryHearing Loss SuddenSensory SystemsHearing recoveryTreatment OutcomeEndocrinologyOtorhinolaryngologychemistryIntravenous therapyAnesthesiaSudden sensorineural hearing lossInjections IntravenousAudiometry Pure-ToneFemaleSteroidsNeurology (clinical)businessOtology & Neurotology
researchProduct

Intratympanic Dexamethasone and Hyaluronic Acid in Patients with Low-Frequency and Ménière's-Associated Sudden Sensorineural Hearing Loss

2005

Steroids are widely used for the treatment of cochleovestibular disorders. Direct steroid application in the middle ear cavity, when combined with a round window membrane permeability-modulating substance, increases the level of the steroid reaching the target cells. We measured hearing in patients with idiopathic isolated low-frequency sensorineural hearing loss and in patients with sudden sensorineural hearing loss and a history of Ménière's disease. Contradictory reports about effectiveness of intratympanic steroid therapy on vertigo control and hearing improvement in patients with Ménière's disease exist in the literature.Eighteen patients with isolated low-frequency idiopathic sudden s…

AdultMalemedicine.medical_specialtyTympanic MembraneHearing lossHearing Loss SensorineuralAnti-Inflammatory AgentsInjections IntralesionalAudiologyDexamethasoneAdjuvants ImmunologicVertigootorhinolaryngologic diseasesmedicineHumansProspective StudiesHyaluronic AcidProspective cohort studyMeniere DiseaseDexamethasoneRound windowbiologymedicine.diagnostic_testbusiness.industryAuditory ThresholdHearing Loss SuddenMiddle Agedbiology.organism_classificationmedicine.diseaseSensory SystemsTreatment Outcomemedicine.anatomical_structureOtorhinolaryngologyMiddle earAudiometry Pure-ToneFemaleSensorineural hearing lossNeurology (clinical)medicine.symptomAudiometrybusinessmedicine.drugOtology & Neurotology
researchProduct